Page last updated: 2024-09-04

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Recrudescence

dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination has been researched along with Recrudescence in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballard, RA; Clements, JA; Heilbron, DC; Phibbs, CS; Phibbs, RH; Schlueter, MA; Sniderman, SH; Tooley, WH; Wakeley, A1

Trials

1 trial(s) available for dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination and Recrudescence

ArticleYear
Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease.
    Pediatrics, 1991, Volume: 88, Issue:1

    Topics: Administration, Inhalation; Birth Weight; Drug Combinations; Drug Evaluation; Fatty Alcohols; Follow-Up Studies; Humans; Hyaline Membrane Disease; Infant, Newborn; Phosphorylcholine; Polyethylene Glycols; Pulmonary Surfactants; Recurrence; Regression Analysis; Respiration, Artificial; Time Factors

1991